Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorClínica São Germano-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorHospital Pablo Tobon Uribe-
Autor(es): dc.contributorFundaleu-
Autor(es): dc.contributorHospital Italiano de Buenos Aires-
Autor(es): dc.contributorHospital de Clínicas de Porto Alegre-
Autor(es): dc.contributorPesquisa e Inovação-
Autor(es): dc.contributorFundación Santa Fe de Bogota-
Autor(es): dc.contributorInstituto de Oncología Angel H. Roffo-
Autor(es): dc.contributorUniversidade de São Paulo (USP)-
Autor(es): dc.contributorLiga Contra o Cancer-
Autor(es): dc.contributorlnstituto D’or Oncologia-
Autor(es): dc.contributorHospital Italiano La Plata-
Autor(es): dc.contributorHospital Privado Centro Medico de Cordoba SA-
Autor(es): dc.contributorHospital do Servidor Público Estadual-
Autor(es): dc.contributorA.C. Camargo Cancer Center-
Autor(es): dc.contributorHospital Universitário Mayor-
Autor(es): dc.contributorClínica FOSCAL-
Autor(es): dc.contributorClinica de Occidente-
Autor(es): dc.contributorJanssen Research & Development-
Autor(es): dc.contributorJanssen-Cilag-
Autor(es): dc.contributorJanssen-Cilag Ltda-
Autor(es): dc.creatorHungria, Vania-
Autor(es): dc.creatorGaiolla, Rafael-
Autor(es): dc.creatorGalvez, Kenny-
Autor(es): dc.creatorRemaggi, Guillermina-
Autor(es): dc.creatorSchutz, Natalia-
Autor(es): dc.creatorBittencourt, Rosane-
Autor(es): dc.creatorMaiolino, Angelo-
Autor(es): dc.creatorQuintero-Vega, Guillermo-
Autor(es): dc.creatorCugliari, Maria Silvana-
Autor(es): dc.creatorBraga, Walter Moises Tobias-
Autor(es): dc.creatorVillarim, Carolina Colaco-
Autor(es): dc.creatorCrusoe, Edvan-
Autor(es): dc.creatorEnrico, Alicia Ines-
Autor(es): dc.creatorCaiero, Gaston-
Autor(es): dc.creatorBigonha, Jandey-
Autor(es): dc.creatorMoura, Fernanda Lemos-
Autor(es): dc.creatorFigueroa, Jair-
Autor(es): dc.creatorMelo, Claudia Lucia Sossa-
Autor(es): dc.creatorLombana, Milton-
Autor(es): dc.creatorPei, Huiling-
Autor(es): dc.creatorFernandez, Mariana-
Autor(es): dc.creatorSaes, Jaqueline-
Autor(es): dc.creatorTrufelli, Damila Cristina-
Data de aceite: dc.date.accessioned2025-08-21T18:54:30Z-
Data de disponibilização: dc.date.available2025-08-21T18:54:30Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2025-03-25-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1182/bloodadvances.2024013838-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/304516-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/304516-
Descrição: dc.descriptionAlthough systemic therapy for multiple myeloma (MM) has evolved considerably over the past 2 decades, state-of-the-art treatment is not uniformly available in Latin America. In some countries, disparities between the public and private sectors in clinical presentation, access to novel agents, and transplantation are striking, with the public sector lagging. We conducted a multicenter, observational study of patients with MM in 5 Latin American countries (Argentina, Brazil, Colombia, Mexico, and Panama). We enrolled patients aged ≥18 years diagnosed with MM between January 2016 and June 2021, using data collected between May 2019 and June 2022. We categorized institutions as “public” when primarily funded by federal or local government, and “private” when financed mostly or completely by other sources. We analyzed 1029 patients, 1021 of whom could be classified into public (n = 339) and private (n = 682) institutions. These 2 groups differed in many respects, with patients from the latter having better baseline prognostic features (including eligibility to transplantation) and receiving combinations of immunomodulatory drugs and proteasome inhibitors, as well as anti-CD38 antibodies, more frequently than patients from public institutions. Among 960 patients with complete data for this analysis, the median overall survival was 44.6 months in public institutions and 53.3 months in private institutions (hazard ratio, 0.84; 95% confidence interval, 0.67-1.04; P = .109). Our results indicate diagnostic and therapeutic shortcomings in the management of MM in Latin America, with important gaps in patient profile, treatment patterns and long-term outcomes between public and private institutions. This trial was registered at www.clinicaltrials.gov as #NCT03955900.-
Descrição: dc.descriptionClínica São Germano-
Descrição: dc.descriptionMedical School of São Paulo State University-
Descrição: dc.descriptionHospital Pablo Tobon Uribe-
Descrição: dc.descriptionFundaleu-
Descrição: dc.descriptionHospital Italiano de Buenos Aires-
Descrição: dc.descriptionHospital de Clínicas de Porto Alegre-
Descrição: dc.descriptionInstituto Américas de Ensino Pesquisa e Inovação-
Descrição: dc.descriptionFundación Santa Fe de Bogota-
Descrição: dc.descriptionInstituto de Oncología Angel H. Roffo-
Descrição: dc.descriptionHospital São Paulo Federal University of São Paulo-
Descrição: dc.descriptionLiga Contra o Cancer-
Descrição: dc.descriptionlnstituto D’or Oncologia-
Descrição: dc.descriptionHospital Italiano La Plata-
Descrição: dc.descriptionHospital Privado Centro Medico de Cordoba SA-
Descrição: dc.descriptionHospital do Servidor Público Estadual-
Descrição: dc.descriptionA.C. Camargo Cancer Center-
Descrição: dc.descriptionHospital Universitário Mayor, Mederi-
Descrição: dc.descriptionFundación Oftalmológica de Santander Clínica FOSCAL-
Descrição: dc.descriptionClinica de Occidente-
Descrição: dc.descriptionJanssen Research & Development-
Descrição: dc.descriptionJanssen-Cilag-
Descrição: dc.descriptionJanssen-Cilag Ltda-
Descrição: dc.descriptionMedical School of São Paulo State University-
Formato: dc.format1293-1302-
Idioma: dc.languageen-
Relação: dc.relationBlood Advances-
???dc.source???: dc.sourceScopus-
Título: dc.titleHealth care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.